<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font18">with </span>
   <span class="font18">for </span>
   <span class="font17">COVID- </span>
   <span class="font17">patients </span>
   <span class="font14">clinical </span>
   <span class="font13">[]. </span>
   <span class="font13">that </span>
   <span class="font13">treatment </span>
   <span class="font13">are </span>
   <span class="font13">has </span>
   <span class="font13">severe </span>
   <span class="font12">[,]. </span>
   <span class="font12">this </span>
   <span class="font12">have </span>
   <span class="font12">The </span>
   <span class="font12">been </span>
   <span class="font12">viral </span>
   <span class="font12">{background </span>
   <span class="font12">coronavirus </span>
   <span class="font12">disease </span>
   <span class="font12">may </span>
   <span class="font12">study </span>
   <span class="font11">was </span>
   <span class="font11">from </span>
   <span class="font11">use </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">also </span>
   <span class="font11">potential </span>
   <span class="font11">HCQ </span>
   <span class="font11">margin </span>
   <span class="font11">trials </span>
   <span class="font11">cases </span>
   <span class="font11">other </span>
   <span class="font11">{border-style </span>
   <span class="font11">against </span>
   <span class="font11">its </span>
   <span class="font11">these </span>
   <span class="font11">mortality </span>
   <span class="font11">px;} </span>
   <span class="font11">respiratory </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">some </span>
   <span class="font11">treatments </span>
   <span class="font11">which </span>
   <span class="font11">IL- </span>
   <span class="font11">all </span>
   <span class="font11">data </span>
   <span class="font11">more </span>
   <span class="font11">stage </span>
   <span class="font11">virus </span>
   <span class="font11">confirmed </span>
   <span class="font11">day </span>
   <span class="font11">pneumonia </span>
   <span class="font11">trial </span>
   <span class="font11">were </span>
   <span class="font10">antiviral </span>
   <span class="font10">might </span>
   <span class="font10">negative </span>
   <span class="font10">studies </span>
   <span class="font10">who </span>
   <span class="font10">â€‰mg </span>
   <span class="font10">(nâ€‰=â€‰) </span>
   <span class="font10">between </span>
   <span class="font10">critically </span>
   <span class="font10">currently </span>
   <span class="font10">group </span>
   <span class="font10">hospitalized </span>
   <span class="font10">ill </span>
   <span class="font10">management </span>
   <span class="font10">novel </span>
   <span class="font10">proposed </span>
   <span class="font10">received </span>
   <span class="font10">ACE </span>
   <span class="font10">This </span>
   <span class="font10">after </span>
   <span class="font10">combination </span>
   <span class="font10">days. </span>
   <span class="font10">efficacy </span>
   <span class="font10">infection </span>
   <span class="font10">shown </span>
   <span class="font10">such </span>
   <span class="font10">while </span>
   <span class="font10">(â€‰mg </span>
   <span class="font10">April </span>
   <span class="font10">China </span>
   <span class="font10">IL-, </span>
   <span class="font10">activity </span>
   <span class="font10">being </span>
   <span class="font10">but </span>
   <span class="font10">care </span>
   <span class="font10">days </span>
   <span class="font10">different </span>
   <span class="font10">drug </span>
   <span class="font10">due </span>
   <span class="font10">patients. </span>
   <span class="font10">rate </span>
   <span class="font10">than </span>
   <span class="font10">therapeutic </span>
   <span class="font10">under </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">based </span>
   <span class="font10">case </span>
   <span class="font10">cells </span>
   <span class="font10">considered </span>
   <span class="font10">dose </span>
   <span class="font10">drugs </span>
   <span class="font10">early </span>
   <span class="font10">effective </span>
   <span class="font10">guidelines </span>
   <span class="font10">human </span>
   <span class="font10">immune </span>
   <span class="font10">including </span>
   <span class="font10">plus </span>
   <span class="font10">pulmonary </span>
   <span class="font10">regarding </span>
   <span class="font10">replication </span>
   <span class="font10">reported </span>
   <span class="font10">results </span>
   <span class="font10">several </span>
   <span class="font10">still </span>
   <span class="font10">therapies </span>
   <span class="font10">two </span>
   <span class="font10">used </span>
   <span class="font10">vaccine </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Chinese </span>
   <span class="font10">[,,]. </span>
   <span class="font10">cases. </span>
   <span class="font10">control </span>
   <span class="font10">higher </span>
   <span class="font10">improvement </span>
   <span class="font10">inhibits </span>
   <span class="font10">px; </span>
   <span class="font10">rapid </span>
   <span class="font10">standard </span>
   <span class="font10">therapy </span>
   <span class="font10">those </span>
   <span class="font10">time </span>
   <span class="font10">{font-family </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">BCG </span>
   <span class="font10">Lopinavir/Ritonavir </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Stage </span>
   <span class="font10">[], </span>
   <span class="font10">al. </span>
   <span class="font10">antibody </span>
   <span class="font10">approved </span>
   <span class="font10">available </span>
   <span class="font10">cohort </span>
   <span class="font10">countries </span>
   <span class="font10">during </span>
   <span class="font10">first </span>
   <span class="font10">font-size </span>
   <span class="font10">had </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">included </span>
   <span class="font10">investigated </span>
   <span class="font10">levels </span>
   <span class="font10">like </span>
   <span class="font10">most </span>
   <span class="font10">order </span>
   <span class="font10">patients, </span>
   <span class="font10">protease </span>
   <span class="font10">protein </span>
   <span class="font10">radiological </span>
   <span class="font10">randomized </span>
   <span class="font10">receptor </span>
   <span class="font10">safety </span>
   <span class="font10">sensitivity </span>
   <span class="font10">should </span>
   <span class="font10">syndrome </span>
   <span class="font10">their </span>
   <span class="font10">â€" </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Engl </span>
   <span class="font10">LPV/ </span>
   <span class="font10">according </span>
   <span class="font10">adults </span>
   <span class="font10">among </span>
   <span class="font10">controlled </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">cytokine </span>
   <span class="font10">daily </span>
   <span class="font10">double; </span>
   <span class="font10">factor </span>
   <span class="font10">hand, </span>
   <span class="font10">high </span>
   <span class="font10">hypoxia </span>
   <span class="font10">illness </span>
   <span class="font10">infected </span>
   <span class="font10">inflammatory </span>
   <span class="font10">information </span>
   <span class="font10">inhibit </span>
   <span class="font10">not </span>
   <span class="font10">only </span>
   <span class="font10">phase </span>
   <span class="font10">plasma </span>
   <span class="font10">published </span>
   <span class="font10">randomized, </span>
   <span class="font10">recently </span>
   <span class="font10">research </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">showed </span>
   <span class="font10">there </span>
   <span class="font10">ARDS </span>
   <span class="font10">All </span>
   <span class="font10">Elsevier </span>
   <span class="font10">For </span>
   <span class="font10">However, </span>
   <span class="font10">IVIG </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">PCR </span>
   <span class="font10">RTV </span>
   <span class="font10">Severe </span>
   <span class="font10">Some </span>
   <span class="font10">Standard </span>
   <span class="font10">With </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">[]]. </span>
   <span class="font10">al.d </span>
   <span class="font10">already </span>
   <span class="font10">another </span>
   <span class="font10">authors </span>
   <span class="font10">azithromycin </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cases, </span>
   <span class="font10">centre </span>
   <span class="font10">changes </span>
   <span class="font10">concerns </span>
   <span class="font10">convalescent </span>
   <span class="font10">could </span>
   <span class="font10">course </span>
   <span class="font10">elevated </span>
   <span class="font10">emergency </span>
   <span class="font10">especially </span>
   <span class="font10">even </span>
   <span class="font10">example, </span>
   <span class="font10">infections </span>
   <span class="font10">key </span>
   <span class="font10">known </span>
   <span class="font10">lower </span>
   <span class="font10">many </span>
   <span class="font10">monoclonal </span>
   <span class="font10">ongoing </span>
   <span class="font10">only. </span>
   <span class="font10">orally </span>
   <span class="font10">over </span>
   <span class="font10">preliminary </span>
   <span class="font10">promising </span>
   <span class="font10">recent </span>
   <span class="font10">response </span>
   <span class="font10">retrospective </span>
   <span class="font10">risk </span>
   <span class="font10">severity </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">spread </span>
   <span class="font10">stem </span>
   <span class="font10">studies, </span>
   <span class="font10">suggested </span>
   <span class="font10">system </span>
   <span class="font10">targets </span>
   <span class="font10">tested </span>
   <span class="font10">three </span>
   <span class="font10">treatment. </span>
   <span class="font10">vaccination </span>
   <span class="font10">vitro </span>
   <span class="font10">within </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(COVID-): </span>
   <span class="font10">(HCQ) </span>
   <span class="font10">Camostat </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Convalescent </span>
   <span class="font10">France </span>
   <span class="font10">Hospitalized </span>
   <span class="font10">ICU </span>
   <span class="font10">III. </span>
   <span class="font10">IV. </span>
   <span class="font10">Infect </span>
   <span class="font10">Interim </span>
   <span class="font10">Intravenous </span>
   <span class="font10">Leronlimab </span>
   <span class="font10">Med./NEJMoa </span>
   <span class="font10">Other </span>
   <span class="font10">RNA </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">Sepsis </span>
   <span class="font10">Several </span>
   <span class="font10">Since </span>
   <span class="font10">These </span>
   <span class="font10">Transl </span>
   <span class="font10">Treatment </span>
   <span class="font10">Umifenovir </span>
   <span class="font10">United </span>
   <span class="font10">WHO </span>
   <span class="font10">[[], </span>
   <span class="font10">action </span>
   <span class="font10">acute </span>
   <span class="font10">agent </span>
   <span class="font10">antibodies </span>
   <span class="font10">better </span>
   <span class="font10">bold </span>
   <span class="font10">can </span>
   <span class="font10">cell </span>
   <span class="font10">characteristics </span>
   <span class="font10">chloroquine </span>
   <span class="font10">common </span>
   <span class="font10">comparable </span>
   <span class="font10">compared </span>
   <span class="font10">concomitant </span>
   <span class="font10">conducted </span>
   <span class="font10">conversion </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">days, </span>
   <span class="font10">demonstrated </span>
   <span class="font10">disease, </span>
   <span class="font10">em; </span>
   <span class="font10">end </span>
   <span class="font10">enzyme </span>
   <span class="font10">epithelial </span>
   <span class="font10">experience </span>
   <span class="font10">findings </span>
   <span class="font10">following </span>
   <span class="font10">four </span>
   <span class="font10">guidance </span>
   <span class="font10">host </span>
   <span class="font10">immunoglobulin </span>
   <span class="font10">important </span>
   <span class="font10">improve </span>
   <span class="font10">in-vitro </span>
   <span class="font10">interventions </span>
   <span class="font10">into </span>
   <span class="font10">laboratory </span>
   <span class="font10">leads </span>
   <span class="font10">load </span>
   <span class="font10">low </span>
   <span class="font10">low-dose </span>
   <span class="font10">lung </span>
   <span class="font10">mechanisms </span>
   <span class="font10">median </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">new </span>
   <span class="font10">number </span>
   <span class="font10">observed </span>
   <span class="font10">one </span>
   <span class="font10">organ </span>
   <span class="font10">oxygen </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">patient </span>
   <span class="font10">potentially </span>
   <span class="font10">predictive </span>
   <span class="font10">previous </span>
   <span class="font10">pt;} </span>
   <span class="font10">ratio </span>
   <span class="font10">recommended </span>
   <span class="font10">resource </span>
   <span class="font10">seem </span>
   <span class="font10">stages </span>
   <span class="font10">storm </span>
   <span class="font10">sulfate </span>
   <span class="font10">symptoms </span>
   <span class="font10">testing </span>
   <span class="font10">treat </span>
   <span class="font10">treated </span>
   <span class="font10">treating </span>
   <span class="font10">treatment, </span>
   <span class="font10">urgent </span>
   <span class="font10">using </span>
   <span class="font10">widely </span>
   <span class="font10">years </span>
   <span class="font10">years, </span>
   <span class="font10">yet </span>
  </p>
 </body>
</html>
